EA200900474A1 - Способ получения мемантина и его гидрохлорида - Google Patents

Способ получения мемантина и его гидрохлорида

Info

Publication number
EA200900474A1
EA200900474A1 EA200900474A EA200900474A EA200900474A1 EA 200900474 A1 EA200900474 A1 EA 200900474A1 EA 200900474 A EA200900474 A EA 200900474A EA 200900474 A EA200900474 A EA 200900474A EA 200900474 A1 EA200900474 A1 EA 200900474A1
Authority
EA
Eurasian Patent Office
Prior art keywords
memantine
hydrochloride
getting
dimethyladamantane
synthesis
Prior art date
Application number
EA200900474A
Other languages
English (en)
Other versions
EA019303B1 (ru
Inventor
Ярослав Тихи
Мария Мелех
Франц Врецер
Рок Зупет
Йоже Пуцель
Митя Пелко
Original Assignee
Крка, Д.Д. Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Крка, Д.Д. Ново Место filed Critical Крка, Д.Д. Ново Место
Publication of EA200900474A1 publication Critical patent/EA200900474A1/ru
Publication of EA019303B1 publication Critical patent/EA019303B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к синтезу 1-амино-3,5-диметиладамантана ("мемантина") и его гидрохлорида. В частности, описано новое промежуточное соединение (N-хлор-ацетиламино-3,5-диметиладамантан) для синтеза мемантина, а также новый способ получения мемантина и его гидрохлорида с использованием указанного промежуточного соединения.
EA200900474A 2006-10-05 2007-10-05 Способ получения мемантина и его гидрохлорида EA019303B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06020944A EP1908748A1 (en) 2006-10-05 2006-10-05 Process for the preparation of memantine and its hydrochloric acid salt form
PCT/EP2007/008684 WO2008040560A1 (en) 2006-10-05 2007-10-05 Process for the preparation of memantine and its hydrochloric acid salt form

Publications (2)

Publication Number Publication Date
EA200900474A1 true EA200900474A1 (ru) 2009-08-28
EA019303B1 EA019303B1 (ru) 2014-02-28

Family

ID=37735099

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900474A EA019303B1 (ru) 2006-10-05 2007-10-05 Способ получения мемантина и его гидрохлорида

Country Status (5)

Country Link
EP (2) EP1908748A1 (ru)
EA (1) EA019303B1 (ru)
SI (1) SI2097372T1 (ru)
UA (1) UA100367C2 (ru)
WO (1) WO2008040560A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100092564A1 (en) * 2006-12-21 2010-04-15 Jae Han Park Composition of and Method for Preparing Orally Disintegrating Tablets
WO2008079343A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
US20100215740A1 (en) * 2007-10-10 2010-08-26 Rubicon Research Private Limited Taste-masked orally disintegrating tablets of memantine hydrochloride
EP2389351A1 (en) * 2009-01-21 2011-11-30 Merz Pharma GmbH & Co. KGaA A process for preparing memantine
WO2011125062A1 (en) * 2010-04-08 2011-10-13 Hetero Research Foundation Process for the preparation of memantine hydrochloride
EP2882291B1 (en) * 2012-08-07 2017-09-27 ZCL Chemicals Ltd. An improved process for the preparation of memantine hydrochloride
JP6094837B2 (ja) 2013-01-23 2017-03-15 三菱瓦斯化学株式会社 メマンチンの製造プロセス
CN104447352B (zh) * 2013-09-20 2017-01-25 山东方明药业集团股份有限公司 一种盐酸美金刚的制备方法
CN103483205B (zh) * 2013-10-12 2015-02-04 合肥久诺医药科技有限公司 一种高纯度盐酸美金刚的制备方法
CN103524353B (zh) * 2013-10-12 2015-03-25 合肥久诺医药科技有限公司 一种高纯度盐酸美金刚的制备方法
CN103539690B (zh) * 2013-10-12 2015-12-09 合肥久诺医药科技有限公司 一种合成金刚烷胺类药物的中间体及其制备方法和应用
JP2016169166A (ja) * 2015-03-11 2016-09-23 株式会社トクヤマ １‐アミノ‐３，５‐ジメチルアダマンタン塩酸塩の製造方法
US11090277B2 (en) * 2015-12-23 2021-08-17 Laboratorios Bagó S.A. Premixture and pharmaceutical composition for the oral administration of memantine as a permanent suspension or one prepared prior to administering to the patient and optionally by enteral feeding tube and corresponding procedures
CN106966909B (zh) * 2016-09-06 2019-04-12 南京优科制药有限公司 一种盐酸美金刚的纯化方法
JP7250305B2 (ja) * 2018-10-02 2023-04-03 共和薬品工業株式会社 メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法
CN114681423B (zh) * 2022-05-19 2024-02-27 海南林恒制药股份有限公司 一种盐酸美金刚片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3391342A (en) * 1965-11-22 1968-07-02 Janus Control Corp Digital counter
US3391142A (en) * 1966-02-09 1968-07-02 Lilly Co Eli Adamantyl secondary amines
NL7305644A (ru) * 1972-04-20 1973-10-23
US5599998A (en) * 1994-10-24 1997-02-04 Iowa State University Research Foundation, Inc. Method for the synthesis of adamantane amines
CN1400205A (zh) * 2002-08-30 2003-03-05 中国科学院广州化学研究所 美金刚胺盐酸盐的制备方法
RU2006101225A (ru) * 2003-06-16 2006-06-10 Аллерган, Инк. (Us) Пероральные лекарственные формы мемантина
CN1240668C (zh) * 2003-09-10 2006-02-08 上海医药工业研究院 一种新的盐酸美金刚制备方法
CN1709229A (zh) * 2005-06-10 2005-12-21 北京阜康仁生物制药科技有限公司 盐酸美金刚口腔崩解片及其制备方法
PL1820792T3 (pl) 2006-02-21 2012-06-29 Hexal Ag Sposób otrzymywania adamantanoamin

Also Published As

Publication number Publication date
EP2097372A1 (en) 2009-09-09
EP1908748A1 (en) 2008-04-09
WO2008040560A1 (en) 2008-04-10
EP2097372B1 (en) 2017-05-31
SI2097372T1 (sl) 2017-10-30
UA100367C2 (uk) 2012-12-25
EA019303B1 (ru) 2014-02-28

Similar Documents

Publication Publication Date Title
EA200900474A1 (ru) Способ получения мемантина и его гидрохлорида
DE602006009619D1 (de) Verfahren zur herstellung von 1-amino-3,5-dimethyladamantan-hydrochlorid
BRPI0500480A (pt) processo para a sìntese de (1s)-4,5-dimetóxi- 1-(metilaminometil)-benzociclobutano e sais de adição deste, e aplicação na sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
EA200501222A1 (ru) Дигидроптеридиноны, способ их получения и их применение в качестве лекарственных средств
CU23453B7 (es) Pirazolpiridinas sustituidas con carbamato
ECSP077275A (es) Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos
EA200700215A1 (ru) Протеиновые гидролизаты, снижающие давление крови
EA201101015A1 (ru) Способ получения бивалирудина
IL180354A0 (en) Process for the preparation of atomoxetine hydrochloride
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
EA201071121A1 (ru) Способ получения бензопроизводных диоксина
BRPI0415203A (pt) pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
BRPI0413139A (pt) processo para a preparação de l-treonina
BRPI0606659A2 (pt) processos para a preparação de álcoois aminoetoxibenzìlicos
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
EA200801400A1 (ru) Новые производные индолизина, способ их получения и терапевтические композиции на их основе
BR0214971A (pt) Processo para a produção de um imunossupressor
AR051933A1 (es) Proceso para la preparacion de n-(3,5 dicloropirid-4-ilo)-4-difluormetoxi-8-metano sulfonamido-dibenzo[b,d] furano-1-carboxamida
EA200800044A1 (ru) Производные 2,5-бисдиамин[1,4]бензохинона
BRPI0514313A (pt) processo para sintetizar um composto, e, composto
EA200700191A1 (ru) Композиции, содержащие никорандил, способ получения и применение
ATE502007T1 (de) Synthese von optisch reinem (r)-5-(2-aminopropyl)-2-methoxybenzolsulphonami

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU